Literature DB >> 13694948

Decline of the tuberculosis epidemic in Alaska.

G W COMSTOCK, R N PHILIP.   

Abstract

Entities:  

Keywords:  TUBERCULOSIS/epidemiology

Mesh：

Year:  1961        PMID： 13694948      PMCID： PMC1929584     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN： 0094-6214            Impact factor:   2.792


× No keyword cloud information.
  7 in total

1.  Tuberculin sensitivity and tuberculosis among natives of the lower Yukon.

Authors:  G W COMSTOCK; M E PORTER
Journal:  Public Health Rep       Date:  1959-07       Impact factor: 2.792

2.  Community trials of BCG vaccination.

Authors:  C E PALMER; L W SHAW; G W COMSTOCK
Journal:  Am Rev Tuberc       Date:  1958-06

3.  The tuberculosis problem in the Pacific territories: Alaska.

Authors:  E T BLOMQUIST; E S WEISS
Journal:  Trans Annu Meet Natl Tuberc Assoc       Date:  1953

4.  Tuberculin sensitivity of tuberculous patients.

Authors:  C E PALMER; L E BATES
Journal:  Bull World Health Organ       Date:  1952       Impact factor: 9.408

5.  Tuberculin sensitivity in Alaska.

Authors:  E S WEISS
Journal:  Public Health Rep       Date:  1953-01       Impact factor: 2.792

6.  Public Health Weekly Reports for MARCH 2, 1934.

Authors: 
Journal:  Public Health Rep       Date:  1934-03-02       Impact factor: 2.792

7.  Public health in Alaska--United States frontier.

Authors:  C E ALBRECHT
Journal:  Am J Public Health Nations Health       Date:  1952-06
  7 in total
  11 in total

1.  Ambulatory chemotherapy in Alaska.

Authors:  M E PORTER; G W COMSTOCK
Journal:  Public Health Rep       Date:  1962-12       Impact factor: 2.792

2.  Limited impact of tuberculosis control in Hong Kong: attributable to high risks of reactivation disease.

Authors:  E Vynnycky; M W Borgdorff; C C Leung; C M Tam; P E M Fine
Journal:  Epidemiol Infect       Date:  2007-08-03       Impact factor: 2.451

Review 3.  Transforming the fight against tuberculosis: targeting catalysts of transmission.

Authors:  David W Dowdy; Andrew S Azman; Emily A Kendall; Barun Mathema
Journal:  Clin Infect Dis       Date:  2014-06-30       Impact factor: 9.079

4.  The realized and unrealized benefits from chemotherapy for Tuberculosis.

Authors:  T Moulding
Journal:  Public Health Rep       Date:  1967-09       Impact factor: 2.792

5.  Community isoniazid prophylaxis program in an underdeveloped area of Alaska.

Authors:  M L Hanson; G W Comstock; C E Haley
Journal:  Public Health Rep       Date:  1967-12       Impact factor: 2.792

6.  Availability and use of medical services in an Alaskan Eskimo community.

Authors:  R Fortuine
Journal:  Public Health Rep       Date:  1969-10       Impact factor: 2.792

7.  Tuberculosis among American Indians of the contiguous United States.

Authors:  H L Rieder
Journal:  Public Health Rep       Date:  1989 Nov-Dec       Impact factor: 2.792

8.  Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden setting.

Authors:  Emily A Kendall; Andrew S Azman; Gary Maartens; Andrew Boulle; Robert J Wilkinson; David W Dowdy; Molebogeng X Rangaka
Journal:  AIDS       Date:  2019-03-01       Impact factor: 4.177

9.  Impact of mass-screening on tuberculosis incidence in a prospective cohort of Brazilian prisoners.

Authors:  Dayse Sanchez Guimarães Paião; Everton Ferreira Lemos; Andrea da Silva Santos Carbone; Renata Viebrantz Enne Sgarbi; Alexandre Laranjeira Junior; Fellipe Matos da Silva; Letícia Marques Brandão; Luciana Squarizi Dos Santos; Vaneli Silva Martins; Simone Simionatto; Ana Rita Coimbra Motta-Castro; Maurício Antônio Pompílio; Juliana Urrego; Albert Icksang Ko; Jason Randolph Andrews; Julio Croda
Journal:  BMC Infect Dis       Date:  2016-10-03       Impact factor: 3.090

Review 10.  Designing and Evaluating Interventions to Halt the Transmission of Tuberculosis.

Authors:  David W Dowdy; Alison D Grant; Keertan Dheda; Edward Nardell; Katherine Fielding; David A J Moore
Journal:  J Infect Dis       Date:  2017-11-03       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.